294 related articles for article (PubMed ID: 18521496)
21. Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
Van Thiel D; Kalodiki E; Wahi R; Litinas E; Haque W; Rao G
Clin Appl Thromb Hemost; 2009; 15(4):389-94. PubMed ID: 19608550
[TBL] [Abstract][Full Text] [Related]
22. Enoxaparin vs. nadroparin for venous thromboembolism prevention: too close to tell?
Tosetto A
J Thromb Haemost; 2006 Aug; 4(8):1691-2. PubMed ID: 16879210
[No Abstract] [Full Text] [Related]
23. Peripheral nerve block catheters and low molecular weight heparin.
Ben-David B; Chelly JE
Anesth Analg; 2007 Apr; 104(4):990-1; author reply 991-2. PubMed ID: 17377121
[No Abstract] [Full Text] [Related]
24. Changes in bone density during long-term administration of low-molecular-weight heparins or acenocoumarol for secondary prophylaxis of venous thromboembolism.
Wawrzyńska L; Tomkowski WZ; Przedlacki J; Hajduk B; Torbicki A
Pathophysiol Haemost Thromb; 2003; 33(2):64-7. PubMed ID: 14624046
[TBL] [Abstract][Full Text] [Related]
25. Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin.
Paciaroni M; Ageno W; Agnelli G
Thromb Haemost; 2008 May; 99(5):978-80. PubMed ID: 18449438
[No Abstract] [Full Text] [Related]
26. Secondary prophylaxis with low molecular weight heparin: the dose?
Horne MK
Thromb Haemost; 2001 Oct; 86(4):1129. PubMed ID: 11686343
[No Abstract] [Full Text] [Related]
27. Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism.
Deitelzweig SB; Becker R; Lin J; Benner J
Thromb Haemost; 2008 Nov; 100(5):810-20. PubMed ID: 18989525
[TBL] [Abstract][Full Text] [Related]
28. Venous thromboembolism in pregnancy.
James AH
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):326-31. PubMed ID: 19228606
[TBL] [Abstract][Full Text] [Related]
29. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
30. Excessive anticoagulation in patients with mild renal insufficiency receiving long-term therapeutic enoxaparin.
Busby LT; Weyman A; Rodgers GM
Am J Hematol; 2001 May; 67(1):54-6. PubMed ID: 11279659
[TBL] [Abstract][Full Text] [Related]
31. Continuous peripheral nerve catheters in patients receiving low molecular weight heparin.
Bleckner LL; Buckenmaier CC
Anesth Analg; 2007 Apr; 104(4):991; author reply 991-2. PubMed ID: 17377123
[No Abstract] [Full Text] [Related]
32. Enoxaparin for the prevention of venous thromboembolism.
Calderon EJ; Varela JM; Gonzalez de la Puente MA
N Engl J Med; 2000 Jan; 342(2):136-7. PubMed ID: 10636758
[No Abstract] [Full Text] [Related]
33. New insights on the role of direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery.
Ageno W; Prandoni P
Thromb Haemost; 2011 Apr; 105(4):571-3. PubMed ID: 21359412
[No Abstract] [Full Text] [Related]
34. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
Heidenreich C; Hohmann V; Bramlage P
Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
[TBL] [Abstract][Full Text] [Related]
35. Enoxaparin in neurosurgical patients.
Connolly ES; Mocco J
N Engl J Med; 1998 Nov; 339(22):1639-40. PubMed ID: 9867528
[No Abstract] [Full Text] [Related]
36. Prevention of venous thromboembolism after orthopedic surgery: the EXPRESS study.
Cimminiello C; Planès A; Samama MM
J Thromb Haemost; 2004 Nov; 2(11):2036-40. PubMed ID: 15550036
[No Abstract] [Full Text] [Related]
37. [Effect of anesthesia and anticoagulant prophylaxis on the occurrence of postoperative thromboembolic complications in orthopedic patients].
Neĭmark MI; Zinovv'eva IE; Deev IT; Dicheskul ML; Smirnova OI; Momot AP
Anesteziol Reanimatol; 2006; (2):35-8. PubMed ID: 16758942
[TBL] [Abstract][Full Text] [Related]
38. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration.
Schobess R; Düring C; Bidlingmaier C; Heinecke A; Merkel N; Nowak-Göttl U
Haematologica; 2006 Dec; 91(12):1701-4. PubMed ID: 17145610
[TBL] [Abstract][Full Text] [Related]
39. Iatrogenic calcinosis cutis following nadroparin injection.
Giorgini S; Martinelli C; Massi D; Lumini A; Mannucci M; Giglioli L
Int J Dermatol; 2005 Oct; 44(10):855-7. PubMed ID: 16207189
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience with nadroparin in patients undergoing dialysis for renal impairment.
Zhang W; Chen X; Chen Y; Chen N
Hemodial Int; 2011 Jul; 15(3):379-94. PubMed ID: 21722301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
